Atlas Trials

Levels of Interleukin-6 andTransforming Growth Factor Beta in HCV Patients Sera

Clinical trial NCT03882307 · UNKNOWN

Trial details

NCT number
NCT03882307
Sponsor
Assiut University
Status
UNKNOWN
Phase
Early Phase 1
Study type
INTERVENTIONAL
Hepatitis C, Chronic
Start date
2022-10-01
Primary completion
2022-11-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.